DHR
Price
$215.85
Change
+$0.15 (+0.07%)
Updated
Oct 4, 2:02 PM EST
20 days until earnings call
WST
Price
$371.41
Change
+$2.64 (+0.72%)
Updated
Oct 4, 2:08 PM EST
22 days until earnings call

Compare trend and price DHR vs WST

Header iconDHR vs WST Comparison
Open Charts DHR vs WSTBanner chart's image
Danaher
Price$215.85
Change+$0.15 (+0.07%)
Volume$100
CapitalizationN/A
West Pharmaceutical Services
Price$371.41
Change+$2.64 (+0.72%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
DHR vs WST Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
DHR vs. WST commentary
Oct 04, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHR is a StrongBuy and WST is a StrongSell.

COMPARISON
Comparison
Oct 04, 2023
Stock price -- (DHR: $215.70 vs. WST: $368.83)
Brand notoriety: DHR and WST are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DHR: 184% vs. WST: 81%
Market capitalization -- DHR: $157.82B vs. WST: $27.37B
DHR [@Medical Specialties] is valued at $157.82B. WST’s [@Medical Specialties] market capitalization is $27.37B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $6.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DHR’s FA Score shows that 1 FA rating(s) are green whileWST’s FA Score has 2 green FA rating(s).

  • DHR’s FA Score: 1 green, 4 red.
  • WST’s FA Score: 2 green, 3 red.
According to our system of comparison, WST is a better buy in the long-term than DHR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DHR’s TA Score shows that 5 TA indicator(s) are bullish while WST’s TA Score has 4 bullish TA indicator(s).

  • DHR’s TA Score: 5 bullish, 5 bearish.
  • WST’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both DHR and WST are a bad buy in the short-term.

Price Growth

DHR (@Medical Specialties) experienced а -1.58% price change this week, while WST (@Medical Specialties) price change was -1.75% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.78%. For the same industry, the average monthly price growth was -8.88%, and the average quarterly price growth was -10.19%.

Reported Earning Dates

DHR is expected to report earnings on Oct 24, 2023.

WST is expected to report earnings on Oct 26, 2023.

Industries' Descriptions

@Medical Specialties (-1.78% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for DHR with price predictions.
OPEN
A.I.dvisor published
a Summary for WST with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
DHR($158B) has a higher market cap than WST($27.4B). WST has higher P/E ratio than DHR: WST (54.05) vs DHR (25.06). WST YTD gains are higher at: 56.988 vs. DHR (-8.084). DHR has higher annual earnings (EBITDA): 9.78B vs. WST (743M). WST has less debt than DHR: WST (311M) vs DHR (19.9B). DHR has higher revenues than WST: DHR (30.4B) vs WST (2.87B).
DHRWSTDHR / WST
Capitalization158B27.4B577%
EBITDA9.78B743M1,316%
Gain YTD-8.08456.988-14%
P/E Ratio25.0654.0546%
Revenue30.4B2.87B1,061%
Total CashN/A796M-
Total Debt19.9B311M6,399%
FUNDAMENTALS RATINGS
DHR vs WST: Fundamental Ratings
DHR
WST
OUTLOOK RATING
1..100
7158
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
86
Overvalued
PROFIT vs RISK RATING
1..100
1423
SMR RATING
1..100
6247
PRICE GROWTH RATING
1..100
5846
P/E GROWTH RATING
1..100
7614
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DHR's Valuation (63) in the Medical Specialties industry is in the same range as WST (86). This means that DHR’s stock grew similarly to WST’s over the last 12 months.

DHR's Profit vs Risk Rating (14) in the Medical Specialties industry is in the same range as WST (23). This means that DHR’s stock grew similarly to WST’s over the last 12 months.

WST's SMR Rating (47) in the Medical Specialties industry is in the same range as DHR (62). This means that WST’s stock grew similarly to DHR’s over the last 12 months.

WST's Price Growth Rating (46) in the Medical Specialties industry is in the same range as DHR (58). This means that WST’s stock grew similarly to DHR’s over the last 12 months.

WST's P/E Growth Rating (14) in the Medical Specialties industry is somewhat better than the same rating for DHR (76). This means that WST’s stock grew somewhat faster than DHR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DHRWST
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
46%
MACD
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
50%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
54%
Advances
ODDS (%)
Bullish Trend 20 days ago
63%
Bullish Trend 21 days ago
74%
Declines
ODDS (%)
Bearish Trend 13 days ago
54%
Bearish Trend 2 days ago
52%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
53%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PCYO9.540.03
+0.32%
Pure Cycle Corp
ULCC4.53-0.04
-0.88%
Frontier Group Holdings
CWAN19.10-0.28
-1.44%
Clearwater Analytics Holdings
GM31.38-1.09
-3.36%
General Motors Company
APWC1.38-0.10
-6.76%
Asia Pacific Wire & Cable Corp Ltd